Lyell Immunopharma, Inc. (LYEL)

21.25 -3.52 (-14.23%) USD  |  NASDAQ  |  Mar 13, 16:00
21.22 -0.03 (-0.14%) After-Hours: 20:00
More

Lyell Immunopharma EV to CFO

EV to CFO Chart

View EV to CFO for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade

EV to CFO Related Metrics

EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade